Abstract
The engineering of technologies for heart valve replacement (i.e., heart valve engineering) is an exciting and evolving field. Since the first valve replacement, technology has progressed by leaps and bounds. Innovations emerge frequently and supply patients and physicians with new, increasingly efficacious and less invasive treatment options. As much as any other field in medicine the treatment of heart valve disease has experienced a renaissance in the last 10 years. Here we review the currently available technologies and future options in the surgical and transcatheter treatment of aortic valve disease. Different valves from major manufacturers are described in details with their applications.
Similar content being viewed by others
References
Alavi, S. H., E. M. Groves, and A. Kheradvar. The effects of transcatheter valve crimping on pericardial leaflets. Ann. Thorac. Surg. 97:1260–1266, 2014.
Alemu, Y., G. Girdhar, M. Xenos, J. Sheriff, J. Jesty, S. Einav, and D. Bluestein. Design optimization of a mechanical heart valve for reducing valve thrombogenicity-a case study with ats valve. ASAIO J. 56:389–396, 2010.
Amahzoune, B., P. Bruneval, B. Allam, A. Lafont, J.-N. Fabiani, and R. Zegdi. Traumatic leaflet injury during the use of percutaneous valves: a comparative study of balloon- and self-expandable valved stents. Eur. J. Cardio Thorac. Surg. 43:488–493, 2013.
Aupart, M. R., A. Mirza, Y. A. Meurisse, A. L. Sirinelli, P. H. Neville, and M. A. Marchand. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J. Heart Valve Dis. 15:768–775, 2006; (discussion 775-766).
Bach, D. S., T. David, M. Yacoub, J. Pepper, B. Goldman, J. Wood, E. Verrier, M. Petracek, V. Aldrete, and M. Rosenbloom. Hemodynamics and left ventricular mass regression following implantation of the toronto SPV stentless porcine valve. Am. J. Cardiol. 82:1214–1219, 1998.
Bach, D. S., M. P. Sakwa, M. Goldbach, M. R. Petracek, R. W. Emery, and F. W. Mohr. Hemodynamics and early clinical performance of the st. Jude medical regent mechanical aortic valve. Ann. Thorac. Surg. 74:2003–2009, 2002.
Bach, D. S., N. D. Kon, J. G. Dumesnil, C. F. Sintek, and D. B. Doty. Ten-year outcome after aortic valve replacement with the freestyle stentless bioprosthesis. Ann. Thorac. Surg. 80:480–487, 2005.
Benson, A. M., K. Omrane, E. M. Graves, A. L. Haas, E. Bryant, M. Mandalaywala, and A. Mueller. Synthesis of a low thrombogenic heart valve coating with horseradish peroxidase. Polym. Adv. Technol. 16:117–122, 2005.
Blais, C., J. G. Dumesnil, R. Baillot, S. Simard, D. Doyle, and P. Pibarot. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 108:983–988, 2003.
Borger, M. A., J. Ivanov, S. Armstrong, D. Christie-Hrybinsky, C. M. Feindel, and T. E. David. Twenty-year results of the hancock ii bioprosthesis. J. Heart Valve Dis. 15:49–56, 2006.
Borger, M. A., A. F. Nette, M. Maganti, and C. M. Feindel. Carpentier-edwards perimount magna valve versus medtronic hancock ii: a matched hemodynamic comparison. Ann. Thorac. Surg. 83:2054–2058, 2007.
Bottio, T., L. Caprili, D. Casarotto, and G. Gerosa. Small aortic annulus: the hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J. Thorac. Cardiovasc. Surg. 128:457–462, 2004.
Bradley, S. M. Aortic valve insufficiency in the teenager and young adult: the role of prosthetic valve replacement. World J. Pediatr. Congenit. Heart Surg. 4:397–402, 2013.
Bruschi, G., De Marco, F., Martinelli, L., Klugmann, S. Corevalve® transcatheter self-expandable aortic bioprosthesis. 2013.
Carabello, B. A., and W. J. Paulus. Aortic stenosis. Lancet 373:956–966, 2009.
Carrier, M., M. Pellerin, A. Basmadjian, D. Bouchard, L. P. Perrault, R. Cartier, P. Page, P. Demers, and Y. Hébert. Fifteen years of clinical and echocardiographic follow up with the carbomedics heart valve. J. Heart Valve Dis. 15:67, 2006.
Celiento, M., L. Filaferro, A. D. Milano, G. Anastasio, G. Ferrari, U. Bortolotti. Single center experience with the sorin bicarbon prosthesis: A 17-year clinical follow-up. J. Thorac. Cardiovas. Surg. 2013.
Chambers, J. B., J. L. Pomar, C. A. Mestres, and G. M. Palatianos. Clinical event rates with the on-x bileaflet mechanical heart valve: a multicenter experience with follow-up to 12 years. J. Thorac. Cardiovasc. Surg. 145:420–424, 2013.
Cheema, F. H., N. Hussain, A. P. Kossar, and G. Polvani. Patents and heart valve surgery—i: mechanical valves. Recent Pat. Cardiovasc. Drug Discov. 8:17–34, 2013.
Convelbo, C., P. Guetat, M. Cambillau, B. Allam, P. Bruneval, A. Lafont, and R. Zegdi. Crimping and deployment of balloon-expandable valved stents are responsible for the increase in the hydraulic conductance of leaflets. Eur. J. Cardio Thorac. Surg. 44:1045–1050, 2013.
Cox, J. L., N. Ad, K. Myers, M. Gharib, and R. Quijano. Tubular heart valves: a new tissue prosthesis design—preclinical evaluation of the 3f aortic bioprosthesis. J. Thorac. Cardiovasc. Surg. 130:520–527, 2005.
Cunanan, C. M., C. M. Cabiling, T. T. Dinh, S. Shen, P. Tran-Hata, J. H. Rutledge, III, and M. C. Fishbein. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann. Thorac. Surg. 71:S417–S421, 2001.
Dasi, L. P., H. A. Simon, P. Sucosky, and A. P. Yoganathan. Fluid mechanics of artificial heart valves. Clin. Exp. Pharmacol. Physiol. 36:225–237, 2009.
de Buhr, W., S. Pfeifer, J. Slotta-Huspenina, E. Wintermantel, G. Lutter, and W. A. Goetz. Impairment of pericardial leaflet structure from balloon-expanded valved stents. J. Thorac. Cardiovasc. Surg. 143:1417–1421, 2012.
Dell’Aquila, A. M., D. Schlarb, S. R. Schneider, J. R. Sindermann, A. Hoffmeier, G. Kaleschke, S. Martens, and A. Rukosujew. Clinical and echocardiographic outcomes after implantation of the trifecta aortic bioprosthesis: an initial single-centre experience. Interact. Cardiovasc. Thorac. Surg. 16:112–115, 2013.
Desai, N. D., O. Merin, G. N. Cohen, J. Herman, S. Mobilos, J. Y. Sever, S. E. Fremes, B. S. Goldman, and G. T. Christakis. Long-term results of aortic valve replacement with the st. Jude toronto stentless porcine valve. Ann. Thorac. Surg. 78:2076–2083, 2004.
Emery, R. W., G. J. Van Nooten, and P. J. Tesar. The initial experience with the ATS medical mechanical cardiac valve prosthesis. Ann. Thorac. Surg. 75:444–452, 2003.
Emery, R. W., C. C. Krogh, D. J. Jones, D. M. Nicoloff, D. P. Blake, and K. V. Arom. A five-year follow up of the ATS mechanical heart valve. J. Heart Valve Dis. 13:231–238, 2004.
Falahapisheh, A., and A. Kheradvar. High-speed particle image velocimetry to assess cardiac fluid dynamics in vitro: from performance to validation. Eur. J. Mech. B/Fluids 35:2–8, 2012.
Fallon, A. M., L. P. Dasi, U. M. Marzec, S. R. Hanson, and A. P. Yoganathan. Procoagulant properties of flow fields in stenotic and expansive orifices. Ann. Biomed. Eng. 36:1–13, 2008.
Fish R. D., D. Paniagua, Ureña P, Chevalier B. The colibri heart valve: Theory and practice in the achievement of a low-profile, pre-mounted, pre-packaged TAVI valve. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9:S111, 2013.
Fisher, J. Comparative study of the hydrodynamic function of six size 19 mm bileaflet heart valves. Eur. J. Cardio Thorac. Surg. 9:692–696, 1995.
Flameng, W., F. Rega, M. Vercalsteren, P. Herijgers, and B. Meuris. Antimineralization treatment and patient-prosthesis mismatch are major determinants of the onset and incidence of structural valve degeneration in bioprosthetic heart valves. J. Thorac. Cardiovasc. Surg. 147:1219–1224, 2014.
Forleo, M., and L. P. Dasi. Effect of hypertension on the closing dynamics and lagrangian blood damage index measure of the b-datum regurgitant jet in a bileaflet mechanical heart valve. Ann. Biomed. Eng. 42:110–122, 2014.
Gallegos, R. P., A. L. Rivard, P. T. Suwan, S. Black, S. Bertog, U. Steinseifer, A. Armien, M. Lahti, and R. W. Bianco. In-vivo experience with the triflo trileaflet mechanical heart valve. J Heart Valve Dis. 15:791–799, 2006.
Goldhaber, S. Z. “Bridging” and mechanical heart valves: perils, promises, and predictions. Circulation 113:470–472, 2006.
Gooley, R., P. Antonis, and I. T. Meredith. The next era of transcatheter aortic valve replacement: a case illustrating the benefit of a fully re-positionable, re-sheathable, and retrievable prosthesis. Catheter. Cardiovasc. Interv. 83:831–835, 2014.
Groves, E. M., A. Falahatpisheh, J. L. Su, and A. Kheradvar. The effects of positioning of transcatheter aortic valve on the fluid dynamics of the aortic root. ASAIO J. 60(5):545–552, 2014.
Grube, E., J.-M. Sinning, and A. Vahanian. The year in cardiology 2013: valvular heart disease (focus on catheter-based interventions). Eur. Heart J. 35:490–495, 2014.
Haussig, S., G. Schuler, and A. Linke. Worldwide tavi registries: What have we learned? Clin. Res. Cardiol. 2:1–10, 2014.
Holzhey, D., A. Linke, H. Treede, S. Baldus, S. Bleiziffer, A. Wagner, J. Börgermann, W. Scholtz, J.-L. Vanoverschelde, and V. Falk. Intermediate follow-up results from the multicenter engager european pivotal trial. Ann. Thorac. Surg. 96:2095–2100, 2013.
Ielasi, A., A. Latib, and M. Tespili. Current and new-generation transcatheter aortic valve devices: an update on emerging technologies. Expert Rev. Cardiovasc. Ther. 11:1393–1405, 2013.
Jin, X. Y., C. Ratnatunga, and R. Pillai. Performance of edwards prima stentless aortic valve over eight years. Sem. Thorac. Cardiovasc. Surg. 13:163–167, 2001.
Jun, B. H., N. Saikrishnan, and A. P. Yoganathan. Micro particle image velocimetry measurements of steady diastolic leakage flow in the hinge of a st. Jude medical((r)) regent mechanical heart valve. Ann. Biomed. Eng. 42:526–540, 2014.
Kaufmann, T. A., T. Linde, E. Cuenca-Navalon, C. Schmitz, M. Hormes, T. Schmitz-Rode, and U. Steinseifer. Transient, three-dimensional flow field simulation through a mechanical, trileaflet heart valve prosthesis. ASAIO J. 57:278–282, 2011.
Kelly, S., P. Verdonck, J. Vierendeels, K. Riemslagh, E. Dick, and G. Van Nooten. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int. J. Artif. Org. 22:754–763, 1999.
Kempfert, J., H. Treede, A. J. Rastan, M. Schönburg, M. Thielmann, S. Sorg, F.-W. Mohr, and T. Walther. Transapical aortic valve implantation using a new self-expandable bioprosthesis (acurate ta™): 6-month outcomes. Eur. J. Cardio Thorac. Surg. 43:52–57, 2013.
Khawaja, M. Z., R. Rajani, A. Cook, A. Khavandi, A. Moynagh, S. Chowdhary, M. S. Spence, S. Brown, S. Q. Khan, N. Walker, U. Trivedi, N. Hutchinson, A. J. De Belder, N. Moat, D. J. Blackman, R. D. Levy, G. Manoharan, D. Roberts, S. S. Khogali, P. Crean, S. J. Brecker, A. Baumbach, M. Mullen, J.-C. Laborde, and D. Hildick-Smith. Permanent pacemaker insertion after corevalve transcatheter aortic valve implantation: incidence and contributing factors (the uk corevalve collaborative). Circulation 123:951–960, 2011.
Kheradvar, A., H. Houle, G. Pedrizzetti, G. Tonti, T. Belcik, and M. Ashraf. Lindner, J.R., Gharib, M., Sahn, D. Echocardiographic particle image velocimetry: a novel technique for quantification of left ventricular blood vorticity pattern. J. Am. Soc. Echocardiogr. 23:3102–3111, 2010.
Kiefer, P., F. Gruenwald, J. Kempfert, H. Aupperle, J. Seeburger, F. W. Mohr, and T. Walther. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann. Thorac. Surg. 92:155–160, 2011.
King, M., T. David, and J. Fisher. An initial parametric study on fluid flow through bileaflet mechanical heart valves using computational fluid dynamics. Proc. Inst. Mech. Eng. Part H 208:63–72, 1994.
Kodali, S. K., M. R. Williams, C. R. Smith, L. G. Svensson, J. G. Webb, R. R. Makkar, G. P. Fontana, T. M. Dewey, V. H. Thourani, and A. D. Pichard. Two-year outcomes after transcatheter or surgical aortic-valve replacement. New Engl. J. Med. 366:1686–1695, 2012.
Leon, M. B., C. R. Smith, M. Mack, D. C. Miller, J. W. Moses, L. G. Svensson, E. M. Tuzcu, J. G. Webb, G. P. Fontana, and R. R. Makkar. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Engl. J. Med. 363:1597–1607, 2010.
Levy, F., E. Donal, L. Bière, C. Szymanski, J. P. Remadi, E. Flécher, O. Fouquet, A. Leguerrier, and C. Tribouilloy. Hemodynamic performance during exercise of the new st. Jude trifecta aortic bioprosthesis: results from a french multicenter study. J. Am. Soc. Echocardiogr. 27:590–597, 2014.
Marchand, M. A., M. R. Aupart, R. Norton, I. R. Goldsmith, L. C. Pelletier, M. Pellerin, T. Dubiel, W. J. Daenen, P. Herijgers, and F. P. Casselman. Fifteen-year experience with the mitral carpentier-edwards perimount pericardial bioprosthesis. Ann. Thorac. Surg. 71:S236–S239, 2001.
Matthews, A. M. The development of the starr-edwards heart valve. Texas Heart Inst. J. 25:282–293, 1998.
Miraldi, F., L. Spagnesi, D. Tallarico, G. Di Matteo, and G. Brancaccio. Sorin stentless pericardial valve versus carpentier–edwards perimount pericardial bioprosthesis: is it worthwhile to struggle? Int. J. Cardiol. 118:253–255, 2007.
Mohammadi, S., D. Kalavrouziotis, P. Voisine, E. Dumont, D. Doyle, J. Perron, and F. Dagenais. Bioprosthetic valve durability after stentless aortic valve replacement: the effect of implantation technique. Ann. Thorac. Surg. 97:2011–2018, 2014.
Naidoo, R., B. Pearse, P. Tesar, S. Yap, A. Barnett, and T. Fayers. Long-term outcomes following medtronic open pivot valved conduit. J Heart Valve Dis. 23:105–111, 2014.
Nishimura, R. A., C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin, R. A. Guyton, P. T. O’Gara, C. E. Ruiz, N. J. Skubas, and P. Sorajja. AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines. J. Am. Coll. Cardiol. 63:e57–e185, 2014.
Northrup, 3rd, W. F., R. W. Emery, D. M. Nicoloff, T. J. Lillehei, A. R. Holter, and D. P. Blake. Opposite trends in coronary artery and valve surgery in a large multisurgeon practice, 1979–1999. Ann. Thorac. Surg. 77:488–495, 2004.
Offstad, J., K. Andersen, P. Paulsson, J. Andreasson, U. Kjellman, O. Lundblad, K. G. Engstrøm, R. Haaverstad, and J. L. Svennevig. The scandinavian multicenter hemodynamic evaluation of the SJM regent aortic valve. J. Cardiothorac. Surg. 6:163, 2011.
Piazza, N., and J. Gregoire. Images in clinical medicines. Starr-edwards heart valves. New Engl. J. Med. 358:e24, 2008.
Pibarot, P., and J. G. Dumesnil. Prosthetic heart valves selection of the optimal prosthesis and long-term management. Circulation 119:1034–1048, 2009.
Pillai, R., C. Ratnatunga, J. L. Soon, H. Kattach, A. Khalil, and X. Y. Jin. 3f prosthesis aortic cusp replacement: implantation technique and early results. Asian Cardiovasc. Thorac. Ann. 18:13–16, 2010.
Prifti, E., M. Bonacchi, A. Baboci, K. Krakulli, and G. Giunti. Early and mid-term functional and hemodynamic evaluation of the st. Jude medical regent 17 mm aortic valve mechanical prosthesis. J. Heart Valve Dis. 23:112–121, 2014.
Puskas, J., M. Gerdisch, D. Nichols, R. Quinn, C. Anderson, B. Rhenman, L. Fermin, M. McGrath, B. Kong, and C. Hughes. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-x valve anticoagulation clinical trial randomized food and drug administration investigational device exemption trial. J. Thorac. Cardiovasc. Surg. 147(1202–1211):e1202, 2014.
Rahimtoola, S. H. Choice of prosthetic heart valve in adults an update. J. Am. Coll. Cardiol. 55:2413–2426, 2010.
Reyes, G., S. Badia, P. Alvarez, C. Kallmeyer, S. Rodriguez, A. Sarraj, and J. Bustamante. Results of aortic valve replacement with the supra-annular sorin bicarbon overline prosthesis. J. Heart Valve Dis. 21:358–363, 2012.
Riess, F.-C., R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese. Hemodynamic performance of the medtronic mosaic porcine bioprosthesis up to ten years. Ann. Thorac. Surg. 83:1310–1318, 2007.
Riess, F.-C., E. Cramer, L. Hansen, S. Schiffelers, G. Wahl, J. Wallrath, S. Winkel, and P. Kremer. Clinical results of the medtronic mosaic porcine bioprosthesis up to 13 years. Eur. J. Cardio Thorac. Surg. 37:145–153, 2010.
Ross, Jr., J., and E. Braunwald. Aortic stenosis. Circulation 38:61–67, 1968.
Rudolph, T. K., and S. Baldus, Jenavalve-transfemoral technology. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9:S101, 2013.
Sato, M., H. Harasaki, K. E. Wika, M. V. Soloviev, and A. S. Lee. Blood compatibility of a newly developed trileaflet mechanical heart valve. ASAIO J. 49:117–122, 2003.
Schoen, F. J., and R. J. Levy. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann. Thorac. Surg. 79:1072–1080, 2005.
Schofer, J., A. Colombo, S. Klugmann, J. Fajadet, F. DeMarco, D. Tchétché, F. Maisano, G. Bruschi, A. Latib, and K. Bijuklic. Prospective multicenter evaluation of the direct flow medical® transcatheter aortic valve. J. Am. Coll. Cardiol. 63:763–768, 2014.
Schwarz, F., P. Baumann, J. Manthey, M. Hoffmann, G. Schuler, H. C. Mehmel, W. Schmitz, and W. Kubler. The effect of aortic valve replacement on survival. Circulation 66:1105–1110, 1982.
Shipkowitz, T., J. Ambrus, J. Kurk, and K. Wickramasinghe. Evaluation technique for bileaflet mechanical valves. J. Heart Valve Dis. 11:275–282, 2002.
Smith, C. R., M. B. Leon, M. J. Mack, D. C. Miller, J. W. Moses, L. G. Svensson, E. M. Tuzcu, J. G. Webb, G. P. Fontana, and R. R. Makkar. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Engl. J. Med. 364:2187–2198, 2011.
Valfrè, C., P. Ius, G. Minniti, L. Salvador, T. Bottio, F. Cesari, G. Rizzoli, and G. Gerosa. The fate of hancock ii porcine valve recipients 25 years after implant. Eur. J. Cardio Thorac. Surg. 38:141–146, 2010.
Van Nooten, G. J., F. Caes, K. Francois, Y. Van Belleghem, T. Bové, G. Vandenplas, M. De Pauw, and Y. Taeymans. Fifteen years’ single-center experience with the ATS bileaflet valve. J. Heart Valve Dis. 18:445–452, 2009.
Van Nooten, G. J., T. Bové, Y. Van Belleghem, K. François, F. Caes, G. Vandenplas, M. De Pauw, and Y. Taeymans. Twenty-year single-center experience with the medtronic open pivot mechanical heart valve. Ann. Thorac. Surg. 97:1306–1313, 2014.
Vavuranakis, M., D. Vrachatis, and C. Stefanadis. Corevalve aortic bioprosthesisrepositioning techniques. JACC Cardiovasc. Interv. 3:565–565, 2010.
Wang, J., H. Yao, C. Lim, Y. Zhao, T. Yeo, and N. Hwang. Computational fluid dynamics study of a protruded-hinge bileaflet mechanical heart valve. J. Heart Valve Dis. 10:254–262, 2001; (discussion 263).
Webb, J., and A. Cribier. Percutaneous transarterial aortic valve implantation: what do we know? Eur. Heart J. 32:140–147, 2011.
Wendt, D., M. Thielmann, T. Buck, R.-A. Jánosi, T. Bossert, N. Pizanis, M. Kamler, and H. Jakob. First clinical experience and 1-year follow-up with the sutureless 3f-enable aortic valve prosthesis. Eur. J. Cardio Thorac. Surg. 33:542–547, 2008.
Willson, A. B., J. Rodès-Cabau, D. A. Wood, J. Leipsic, A. Cheung, S. Toggweiler, R. K. Binder, M. Freeman, R. DeLarochellière, and R. Moss. Transcatheter aortic valve replacement with the st. Jude medical portico valvefirst-in-human experience. J. Am. Coll. Cardiol. 60:581–586, 2012.
Wu, J., B. M. Yun, A. M. Fallon, S. R. Hanson, C. K. Aidun, and A. P. Yoganathan. Numerical investigation of the effects of channel geometry on platelet activation and blood damage. Ann. Biomed. Eng. 39:897–910, 2011.
Xenos, M., G. Girdhar, Y. Alemu, J. Jesty, M. Slepian, S. Einav, and D. Bluestein. Device thrombogenicity emulator (DTE)—design optimization methodology for cardiovascular devices: a study in two bileaflet mhv designs. J. Biomech. 43:2400–2409, 2010.
Yankah, C. A., M. Pasic, M. Musci, J. Stein, C. Detschades, H. Siniawski, and R. Hetzer. Aortic valve replacement with the mitroflow pericardial bioprosthesis: durability results up to 21 years. J. Thorac. Cardiovasc. Surg. 136:688–696, 2008.
Yin, W., E. C. Ngwe, and D. A. Rubenstein. A biocompatible flow chamber to study the hemodynamic performance of prosthetic heart valves. ASAIO J. 58:470–480, 2012.
Yun, B. M., J. Wu, H. A. Simon, S. Arjunon, F. Sotiropoulos, C. K. Aidun, and A. P. Yoganathan. A numerical investigation of blood damage in the hinge area of aortic bileaflet mechanical heart valves during the leakage phase. Ann. Biomed. Eng. 40:1468–1485, 2012.
Zegdi, R., P. Bruneval, D. Blanchard, and J.-N. Fabiani. Evidence of leaflet injury during percutaneous aortic valve deployment. Eur. J. Cardio Thorac. Surg. 40:257–260, 2011.
Zingg, U., B. Aeschbacher, C. Seiler, U. Althaus, and T. Carrel. Early experience with the new masters series of st. Jude medical heart valve: in vivo hemodynamic and clinical results in patients with narrowed aortic annulus. J. Heart Valve Dis. 6:535–541, 1997.
Acknowledgments
This review article was prepared after the Mathematics Guiding Bioartificial Heart Valve Design meeting held at the Ohio State University, October 28 to 31, 2013. The authors would like to acknowledge the Mathematical Biosciences Institute and its grant from National Science Foundation (DMS 0931642) that facilitated the meeting.
Conflict of interest
Arash Kheradvar is a co-founder of FOLDA LLC, the manufacturer of FOLDAVALVE. Otherwise the remaining authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Estefanía Peña oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Kheradvar, A., Groves, E.M., Goergen, C.J. et al. Emerging Trends in Heart Valve Engineering: Part II. Novel and Standard Technologies for Aortic Valve Replacement. Ann Biomed Eng 43, 844–857 (2015). https://doi.org/10.1007/s10439-014-1191-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-014-1191-5